🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to see how the body's immune system changes af...
Status
Completed
Location
University of Colorado Hospital CRS
Start Date
TBD
Trial ID
NCT00034086
This study is to understand if the study vaccine (called VLA15) is safe in ...
Status
Completed
Location
UAB Child Health Research Unit (CHRU)
Start Date
2022-12-12
Trial ID
NCT05634811
Treatments Being Tested
This is a research study of the investigational drug 2217LS in healthy volu...
Status
Completed
Location
Celerion Inc.
Start Date
2021-02-11
Trial ID
NCT04863287
Treatments Being Tested
Observer-blind, partially randomized, multi-center dose escalation Phase I ...
Status
Completed
Location
eStudy Site
Start Date
2017-01-31
Trial ID
NCT03010228
Treatments Being Tested
This is a randomized, observer-blind, placebo controlled, multicenter Phase...
Status
Completed
Location
Clinical Research Consulting, LLC
Start Date
2018-12-17
Trial ID
NCT03769194
This study will determine whether patients who have been infected with the ...
Status
Recruiting
Location
National Institutes of Health Clinical Center
Start Date
1996-06-13
Trial ID
NCT00001539
In the Main Study Phase a total of 246 subjects were randomized 2:2:1 into ...
Status
Completed
Location
Clinical Research Consulting, LLC
Start Date
2019-07-01
Trial ID
NCT03970733
Section 1: The purpose of the study is to obtain safety and immunogenicity...
Status
Completed
Location
Medical University Vienna, Dept. of Clinical Pharmacology
Start Date
2011-03-01
Trial ID
NCT01504347
VLA15-221 is a Phase 2 study, which will be conducted in two parts: Main St...
Status
Completed
Location
New England Research Associates
Start Date
2021-03-08
Trial ID
NCT04801420